Peringatan Keamanan

LD50=6800 mg/kg (Orally in mice)

Sulfisoxazole

DB00263

small molecule approved vet_approved

Deskripsi

A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.

Struktur Molekul 2D

Berat 267.304
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

The mean urinary excretion recovery following oral administration of sulfisoxazole is 97% within 48 hours, of which 52% is intact drug, with the remaining as the N4-acetylated metabolite. It is excreted in human milk.

Interaksi Obat

1030 Data
Ivabradine Ivabradine may increase the QTc-prolonging activities of Sulfisoxazole.
Pegvisomant The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Sulfisoxazole.
Nicotine The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfisoxazole.
Lipoic acid The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Sulfisoxazole.
Thiopental The therapeutic efficacy of Thiopental can be increased when used in combination with Sulfisoxazole.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Sulfisoxazole.
Moxifloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Moxifloxacin.
Enoxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Enoxacin.
Pefloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Pefloxacin.
Ciprofloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Ciprofloxacin.
Nalidixic acid The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Nalidixic acid.
Rosoxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Rosoxacin.
Cinoxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Cinoxacin.
Lomefloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Lomefloxacin.
Gatifloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gatifloxacin.
Norfloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Norfloxacin.
Levofloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Levofloxacin.
Gemifloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Gemifloxacin.
Ofloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Ofloxacin.
Fleroxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Fleroxacin.
Technetium Tc-99m ciprofloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
Garenoxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Garenoxacin.
Nemonoxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Nemonoxacin.
Flumequine The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Flumequine.
Enrofloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Enrofloxacin.
Orbifloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Orbifloxacin.
Sarafloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sarafloxacin.
Difloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Difloxacin.
Pazufloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Pazufloxacin.
Prulifloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Prulifloxacin.
Delafloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Delafloxacin.
Sitafloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sitafloxacin.
Oxolinic acid The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Oxolinic acid.
Rufloxacin The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Rufloxacin.
Pipemidic acid The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Pipemidic acid.
Methyclothiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Methyclothiazide.
Chlorthalidone The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Chlorthalidone.
Bendroflumethiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Bendroflumethiazide.
Metolazone The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Metolazone.
Benzthiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Benzthiazide.
Hydroflumethiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Hydroflumethiazide.
Indapamide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Indapamide.
Chlorothiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Chlorothiazide.
Hydrochlorothiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Hydrochlorothiazide.
Trichlormethiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Trichlormethiazide.
Polythiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Polythiazide.
Quinethazone The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Quinethazone.
Cyclopenthiazide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Cyclopenthiazide.
Epitizide The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Epitizide.
Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Sulfisoxazole.
Protriptyline Protriptyline may decrease the hypoglycemic activities of Sulfisoxazole.
Imipramine Imipramine may decrease the hypoglycemic activities of Sulfisoxazole.
Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Sulfisoxazole.
Amoxapine Amoxapine may decrease the hypoglycemic activities of Sulfisoxazole.
Desipramine Desipramine may decrease the hypoglycemic activities of Sulfisoxazole.
Clomipramine Clomipramine may decrease the hypoglycemic activities of Sulfisoxazole.
Amineptine Amineptine may decrease the hypoglycemic activities of Sulfisoxazole.
Dimetacrine Dimetacrine may decrease the hypoglycemic activities of Sulfisoxazole.
Butriptyline Butriptyline may decrease the hypoglycemic activities of Sulfisoxazole.
Dosulepin Dosulepin may decrease the hypoglycemic activities of Sulfisoxazole.
Tianeptine Tianeptine may decrease the hypoglycemic activities of Sulfisoxazole.
Oxaprotiline Oxaprotiline may decrease the hypoglycemic activities of Sulfisoxazole.
Opipramol Opipramol may decrease the hypoglycemic activities of Sulfisoxazole.
Amitriptylinoxide Amitriptylinoxide may decrease the hypoglycemic activities of Sulfisoxazole.
Dibenzepin Dibenzepin may decrease the hypoglycemic activities of Sulfisoxazole.
Quinupramine Quinupramine may decrease the hypoglycemic activities of Sulfisoxazole.
Melitracen Melitracen may decrease the hypoglycemic activities of Sulfisoxazole.
Lofepramine Lofepramine may decrease the hypoglycemic activities of Sulfisoxazole.
Iprindole Iprindole may decrease the hypoglycemic activities of Sulfisoxazole.
Imipramine oxide Imipramine oxide may decrease the hypoglycemic activities of Sulfisoxazole.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfisoxazole.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfisoxazole.
Cyclosporine The risk or severity of renal failure can be increased when Sulfisoxazole is combined with Cyclosporine.
Methenamine Methenamine can cause a decrease in the absorption of Sulfisoxazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Canagliflozin Canagliflozin may increase the hypoglycemic activities of Sulfisoxazole.
Indinavir The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Indinavir.
Etonogestrel The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Etonogestrel.
Desogestrel The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Desogestrel.
Megestrol acetate The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Megestrol acetate.
Levonorgestrel The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Levonorgestrel.
Progesterone The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Progesterone.
Piperazine The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Piperazine.
Medroxyprogesterone acetate The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Medroxyprogesterone acetate.
Niacin The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Niacin.
Epinephrine The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Epinephrine.
Norethisterone The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Norethisterone.
Ethynodiol diacetate The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Ethynodiol diacetate.
Pseudoephedrine The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Pseudoephedrine.
Tacrolimus The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Tacrolimus.
Sirolimus The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Sirolimus.
Etacrynic acid The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Etacrynic acid.
Tipranavir The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Tipranavir.
Norgestimate The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Norgestimate.
Ethinylestradiol The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Ethinylestradiol.

Target Protein

Dihydropteroate synthase folP

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 4 • International brands: 2
Produk
  • Apo Sulfisoxazole Tab 500mg
    Tablet • 500 mg • Oral • Canada • Generic • Approved
  • Novo-soxazole 500mg
    Tablet • 500 mg • Oral • Canada • Generic • Approved
  • Sulfisoxazole
    Tablet • 500 mg • Oral • Canada • Approved
  • Sulfizole Tab 500mg
    Tablet • 500 mg • Oral • Canada • Approved
International Brands
  • Gantrisin — Roche
  • Neoxazol

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul